We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

dinsdag 27 juni 2017

Latest content from npj Precision Oncology: 27 June 2017

If you are unable to see the message below, click here to view.
npj Precision Oncology

Advertisement
npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.

Explore the benefits of submitting your manuscript.

Table of Contents: June 2017

Review Article | 22 June 2017

Targeting the duality of cancer

Jack L. Arbiser, Michael Y. Bonner & Linda C. Gilbert

npj Precision Oncology 1, Article number: 23 | doi:10.1038/s41698-017-0026-x

Comment | 19 June 2017

Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care

Ugljesa Djuric, Gelareh Zadeh, Kenneth Aldape & Phedias Diamandis

npj Precision Oncology 1, Article number: 22 | doi:10.1038/s41698-017-0022-1

Perspective | 15 June 2017

Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?

Grannum R. Sant, Kevin B. Knopf & David M. Albala

npj Precision Oncology 1, Article number: 21 | doi:10.1038/s41698-017-0025-y

Article | 12 June 2017

Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival

Ovidiu C. Andronesi, Morteza Esmaeili, Ronald J. H. Borra, Kyrre Emblem, Elizabeth R. Gerstner et al.

npj Precision Oncology 1, Article number: 20 | doi:10.1038/s41698-017-0020-3

Review Article | 08 June 2017

Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic

Fenil Shah, Derek Logsdon, Richard A. Messmann, Jill C. Fehrenbacher, Melissa L. Fishel et al.

npj Precision Oncology 1, Article number: 19 | doi:10.1038/s41698-017-0023-0

Article | 05 June 2017

Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism

Alessia Lodi, Achinto Saha, Xiyuan Lu, Bo Wang, Enrique Sentandreu et al.

npj Precision Oncology 1, Article number: 18 | doi:10.1038/s41698-017-0024-z

Your email address is in the npj Precision Oncology mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Springer Nature